You just read:

Spyryx Biosciences Announces Successful Completion of Phase 1 Clinical Trial for SPX-101 and Planned Phase 2 Initiation in Cystic Fibrosis During 2017

News provided by

Spyryx Biosciences

06 Feb, 2017, 08:01 ET